2 SUMMARY 20 Cyclic di-GMP (c-di-GMP) is a bacterial second messenger molecule that is important in 21 the biology of Vibrio cholerae, but the molecular mechanisms by which this molecule regulates 22 downstream phenotypes have not been fully characterized. We have previously shown that the 23 Vc2 c-di-GMP-binding riboswitch, encoded upstream of the gene tfoY, functions as an off- 24 switch in response to c-di-GMP. However, the mechanism by which c-di-GMP controls 25 expression of tfoY has not been fully elucidated. During our studies of this mechanism, we 26 determined that c-di-GMP binding to Vc2 also controls the abundance and stability of upstream 27 non-coding small RNAs (sRNA) with 3'-ends located immediately downstream of the Vc2 28 riboswitch. Our results suggest these sRNAs are not generated by transcriptional termination 29 but rather by preventing degradation of the upstream untranslated RNA when c-di-GMP is 30 bound to Vc2. 45 Vibrio cholerae, the causative agent of cholera, lives in diverse environments from 46 environmental aquatic reservoirs to microcompartments within the human host (1). The 47 bacterial second messenger cyclic di-GMP (c-di-GMP) is a central signaling molecule in this 48 bacterium that regulates diverse traits to enable specific adaptation to these changing 49 conditions (2-6). V. cholerae encodes three know transcription factors, VpsR, VpsT, and FlrA, 50 that bind and respond to c-di-GMP to control gene expression by regulating the transcription of 51 genes that mediate biofilm formation, motility, Type II secretion, and DNA repair (4, 5, 7-9). In 52 addition, V. cholerae also encodes two riboswitches that directly bind and respond to changes 53 in the intracellular concentration of c-di-GMP, although the function of these riboswitches in 54 the adaptation of V. cholerae is not well understood (10, 11). 5 to inhibition of TfoY production at intermediate and high c-di-GMP concentrations via an 83 unknown mechanism (10). 84 These studies suggested a model whereby one function of Vc2 was to inhibit production 85 of TfoY from the upstream P 1-tfoY and P 2-tfoY at intermediate and high concentration of c-di-GMP 86 while transcription initiation of tfoY from P 3-tfoY and P 4-tfoY at high c-di-GMP concentrations was 87 induced by c-di-GMP binding to the transcription factor VpsR. At low concentrations of c-di- 88 GMP, TfoY stimulates a rapid, flagellar-based swimming motility that we termed dispersive 89 motility (10), but the function of increased TfoY at high c-di-GMP concentrations is not known. 90 Both in vitro and in vivo evidence suggested that Vc2 inhibits translation of tfoY when bound to 91 c-di-GMP with the ribosome binding site (RBS) of tfoY sequestered by an anti-RBS element 92 located downstream of the Vc2 riboswitch (17, 18), but the mechanism of this inhibition has 93 not yet been fully established in the native sequence of the tfoY 5'-UTR. 94 While further exploring the mechanism by which Vc2 functions as an off-switch, we 95 observed that most of the 3'-ends of transcripts derived from the P 1-tfoY promoter were located 96 at the 3'-end of the Vc2 riboswitch, leading us to elucidate that c-di-GMP binding to the Vc2 97 riboswitch directs accumulation of a novel sRNA. This sRNA, which we named the P 1 -Vc2 sRNA, 98 initiates at the upstream P 1-tfoY promoter and has a 3'-end located at end of the Vc2 riboswitch. 99 The P 1 -Vc2 sRNA is not generated by transcription termination, but rather it accumulates at 100 intermediate and high intracellular c-di-GMP concentrations due to increased stability when 7 of the Vc2 riboswitch (19) . An additional 17% of the sequences contained a 3'-end located 126 further upstream, between -227 to -225 relative to the start of the tfoY coding sequence. This 127 region correlates with the 3'-end of a putative rho-independent terminator located between 128 the P 2-tfoY and P 3-tfoY transcriptional start sites, and it is also the location of the identified VpsR 129 binding sites (10, 20) . Of all the transcripts recovered, 30% featured 3'-end tails containing 130 between 1 and 4 extragenomic nucleotides, almost exclusively adenines, and the majority of 131 these tailed transcripts mapped to the aforementioned sites of the Vc2 aptamer or the 132 upstream rho-independent terminator. These results led us to hypothesize that most of the 133 transcripts initiated from P 1-tfoY and P 2-tfoY exist as sRNAs with the Vc2 riboswitch aptamer 134 located at their 3' ends, and these transcripts did not contain a full-length tfoY sequence, 135 explaining the results of our previous primer extension assay.
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Multiple sRNAs are transcribed from the VC1721-tfoY intergenic region 138 To confirm that the sRNA species predicted by our 3'-RACE analysis were produced by 139 the upstream tfoY promoters in V. cholerae, we performed a series of Northern blots with 140 probes encompassing different segments of the VC1721-tfoY intergenic region against RNA 141 harvested from WT V. cholerae (Fig. 2) . Four probes were used that are complementary to the 142 following regions: probe P 1 (-337 to -272, between the P 1-tfoY and P 2-tfoY start sites), probe P 2 (-143 272 to -191, between the P 2-tfoY and P 3-tfoY start sites), probe P 1+2 (-337 to -191, a larger 144 sequence overlapping the P 1-tfoY to P 3-tfoY start sites), and probe Vc2 (-211 to -94, the sequence 145 of the Vc2 riboswitch). 146 Based on the results of the 3'-RACE assay, we expected to observe specific sRNA 147 transcripts of ~231 nucleotides and ~167 nucleotides in size originating from the P 1-tfoY and P 2-148 tfoY promoters, respectively, with both ending at the immediate 3' edge of the Vc2 aptamer. The 149 presence of the ~231 nucleotide band in all four blots ( Fig. 2B , Lanes 1, 3, 5, and 7), and the 150 presence of the ~167 nucleotide band in all but the probe P 1 blot (Fig. 2 , Lanes 3, 5, and 7), 151 confirms the location of these sRNAs species relative to the promoters and the riboswitch 152 aptamer. We refer to these ~231 nucleotide and ~167 nucleotide transcripts henceforth as the 153 P 1 -Vc2 and P 2 -Vc2 sRNAs, respectively. We also expected to observe a sRNA ~112 nucleotides in 154 size initiated from the P 1-tfoY promoter and ending at the predicted intrinsic terminator 155 immediately downstream of the P 2-tfoY start site. The appearance of this band in the probe P 1 156 and P 1+2 blots and its absence from the probe P 2 blot confirmed the presence of this transcript 157 as well. 158 All of the probes detected a large number of longer RNA species extending into the tfoY 159 coding sequence. This is consistent with our 3'-RACE results identifying multiple 3' RNA ends in 160 this region (Fig. 1 ), and it further suggests that transcription from P 1-tfoY and P 2-tfoY can extend 161 into the tfoY ORF. All the signals in the Northern blot analysis from every probe used were lost 162 in the ΔVc2 mutant, which has a deletion from -359 to -43 on the genome of V. cholerae, 163 showing that these RNA species are specific to the Vc2 riboswitch locus. It is also worth noting 164 that the coding sequence of VC1721, the nearest gene upstream of the riboswitch, is 1,011 165 nucleotides in length. Therefore, based on their size, all the transcripts detected here should 166 have originated downstream from the VC1721 ORF and do not represent run-off transcription 167 from upstream VC1721 mRNA. These data show that the tfoY upstream region produces 9 multiple sRNA species. We name these the P 1 -Vc2-sRNA and P 2 -Vc2-sRNA for the promoter 169 from which they are transcribed.
171
The Vc2 riboswitch and c-di-GMP regulate the abundance of sRNAs 172 To investigate the effect of changes in c-di-GMP on Vc2 riboswitch-containing 173 transcripts in vivo, we performed a higher resolution Northern blot of V. cholerae RNA extracts 174 with probe Vc2 (Fig. 3 ). An initial observation across all of our samples is that there are many 175 different Vc2 riboswitch-containing transcripts between 300 and 1000 nucleotides in length 176 ( Fig. 3 ). The annotated coding sequence of tfoY is 588 nucleotides, therefore the minimum size 177 of full-length tfoY mRNAs should be 926 nucleotides if originating from P 1-tfoY , or 782 178 nucleotides if originating from P 3-tfoY . This implies that a significant number of the transcripts 179 detected contain only a fraction of the annotated tfoY ORF, again consistent with data from our 180 3'-RACE analysis (Fig. 1 ). An integrity analysis of ribosomal RNA from our samples using an 181 Agilent Bioanalyzer confirmed that our RNA was of high quality with little to no degradation 182 occurring during extraction. From this we conclude that most Vc2 riboswitch-containing 183 transcripts are inherently unstable and subject to a high rate of degradation in vivo. 184 Regardless of the transcriptional processes occurring downstream of Vc2, under wild-185 type conditions the P 1 -Vc2 sRNA is the most abundant single RNA species produced that 186 contains the Vc2 sequence ( Fig. 3 , Lane 1). This is consistent with the disparity we had 187 previously observed between the high activity of the P 1-tfoY promoter and its low contribution to 188 total tfoY mRNA (10) . To determine if this sRNA is impacted by changing c-di-GMP levels, we The P 2 -Vc2 sRNA that we previously observed was also evident as a 167-nucleotide 199 band, although it was not as abundant as the P 1 -Vc2 sRNA. The abundance of the P 2 -Vc2 sRNA 200 was slightly decreased upon DGC induction (Fig. 3 , lane 2). This decrease was expected and can 201 be attributed to c-di-GMP-mediated repression of the P 2-tfoY promoter that we have previously 202 reported (10) . The P 2 -Vc2 sRNA was nearly lost upon induction of the PDE (Fig. 3 , lane 4) 203 We hypothesized that the post-transcriptional mechanism responsible for the increase 204 in P 1 -Vc2 sRNAs during changes in c-di-GMP concentrations is dependent on c-di-GMP binding 205 to the Vc2 aptamer. To test this, we generated a number of chromosomal V. cholerae 206 mutations in Vc2 to assess its function. We first constructed a G83U chromosomal mutation in 207 the Vc2 riboswitch as this has been shown to disrupt its structure. When this mutation is We next mutated the C92 and G20 bases in Vc2 to uracils on the V. cholerae 211 chromosome to assess the role of c-di-GMP binding in formation of these sRNAs. The G20 and 212 C92 bases of the Vc2 riboswitch are the sites which directly interact with the guanosine bases of 213 c-di-GMP, and substitutions of uracil at either of these sites significantly disrupts ligand binding 214 without general altering the ligand-free structure (19, 21) . Accordingly, in strains with either 215 single or double mutations at the ligand binding sites we observed loss of the P 1 -Vc2 sRNA ( Fig.   216 3, Lanes 6 and 8). In the C92U mutant, the reduction in abundance from wild-type was 30-fold, 217 and in the G20U/C92U mutant the amount of P 1 -Vc2 sRNA remaining was below the limit of 218 detection. We also observed complete loss of the P 2 -Vc2 sRNA in both of these mutant 219 backgrounds. Expression of the DGC QrgB in the C92U and G20U/C92U strains led to partial 220 recovery of the abundance of the P 1 -Vc2 sRNA in the C92U mutant but virtually no recovery in 221 the G20U/C92U double mutant ( Fig. 3 , Lanes 7 and 9). The relative strength of this recovery in 222 each strain was consistent with the previous biochemical data that the single binding site 223 mutant retains a higher c-di-GMP affinity than the double mutant (19) .
225
The Vc2 riboswitch is not sufficient for transcription termination in vitro 226 The observation that short transcripts are produced which contain the Vc2 aptamer at 227 the 3'-end could be explained if the expression platform of the Vc2 riboswitch functions as a 228 rho-independent transcriptional terminator. No readily apparent terminator structure is located 229 adjacent to the Vc2 riboswitch, and bioinformatic analysis with rho-independent terminator 230 prediction software indicates that the best putative terminator nearby is located at the +193 to 231 +235 region of the tfoY coding sequence, which is more than 300 nucleotides downstream of 232 the 3'-end of the Vc2 aptamer (13, 20, 22). Furthermore, recent publications suggested that Vc2 233 regulates tfoY by controlling translation, not transcription (17, 18). Nevertheless, to 234 experimentally test if the Vc2 aptamer stimulates transcription termination upon binding to c-235 di-GMP, we conducted an in vitro transcription termination assay with E. coli RNA polymerase 236 complexed with σ 70 using a linear PCR template encompassing the genomic region -535 to +120 237 relative to the tfoY coding sequence. 238 Because our transcription template included all of the tfoY promoters, we expected to 239 see full-length transcription products of sizes 458, 394, 314, and 166 nucleotides corresponding 240 to the observed transcriptional start sites of the P 1-tfoY , P 2-tfoY , P 3-tfoY , and P 4-tfoY promoters, 241 respectively, and indeed all of those transcripts were observed ( Fig. 4 , Lane 1). Only two other 242 major transcripts were detected, one >600 nucleotides, likely generated from end-to-end 243 transcription of the template, and one at the ~180 nucleotides size range. Most notably, we did 244 not observe any major transcript in the size range of the P 1 -Vc2 sRNA, which is the most 245 prominent riboswitch-containing transcript generated in vivo. 246 We tested the possibility that Vc2 riboswitch could induce termination by adding 247 exogenous c-di-GMP to the transcription reaction ( Fig. 4 , Lane 2), yet no changes in the size or 248 abundance of transcripts were observed. We also tested the effect of disrupting the structural 249 integrity of the riboswitch by using transcription templates containing the same mutations in 250 the aptamer sequence which had earlier been investigated in vivo. Neither a G83U structural 251 mutation that disrupts tertiary structure of the riboswitch nor the G20U/C92U binding site 252 mutations described earlier had any detectable effect on the production of transcripts in vitro. 253 Therefore, the riboswitch had no impact on transcription of this region in vitro with or without 254 c-di-GMP. 255 To ensure that our reaction conditions were sufficient for detecting potential riboswitch 256 mediated termination, we tested a transcriptional template comprising the ompR-associated 257 class-II c-di-GMP riboswitch of Clostridium difficile, for which a transcription termination 258 mechanism had previously been demonstrated in vitro (23). For this control experiment, 259 addition of c-di-GMP inhibited transcription termination, consistent with the known mechanism 260 of regulation of this riboswitch ( Fig. 4B ). Since we observed c-di-GMP regulation of termination 261 with the control riboswitch but not with the Vc2 riboswitch, we conclude that the Vc2 262 riboswitch does not generate the P 1 -Vc2 and P 2 -Vc2 sRNAs through rho-independent 263 termination. (Fig. 5B) . 277 Our analysis revealed that the P 1 -Vc2 and P 2 -Vc2 sRNA species are significantly more 278 stable than all other transcripts originating from the VC1721-tfoY intergenic locus ( Fig. 5A ). 279 Surprisingly, this analysis also revealed that the P 1 -Vc2 and P 2 -Vc2 sRNAs are not single uniform 280 RNA species, but instead are both represented by a doublet of transcripts with a 5 to 10 281 nucleotide difference in size ( Fig. 5A ). Although it was not determined in this specific assay, 282 these transcripts may represent the most prominent 3'-tailed and non-tailed sRNA species we 283 observed in our 3'-RACE experiments. For the purposes of our quantitative analysis of the 284 amount of transcript remaining, both bands at the P 1 -Vc2 sRNA size range were quantified 285 together as the total amount of P 1 -Vc2 sRNAs. 286 Our RNA stability assay indicated that the individual members of the P 1 -Vc2 sRNA 287 population, on average, persist for longer in the cell when c-di-GMP is elevated ( Fig. 5B ). This 288 difference in stability between conditions of low and high c-di-GMP is a sufficient mechanism to 289 explain the difference in the abundance of the P 1 -Vc2 sRNA between those same conditions. 290 Interestingly, the observed degradation of the P 1 -Vc2 sRNA does not adhere to a simple one-291 phase decay model. Instead, this sRNA appears to be degraded rapidly at early time points and 292 slowly at later time points. To compare the stability of the P 1 -Vc2 sRNA transcripts over time, 293 we calculated the effective half-lives observed for the transcripts relative to each set of time 294 points ( Fig. 5C ). At the first two time points in wild-type conditions, the half-life of the P 1 -Vc2 295 sRNA is less than half a minute, while at later time points this half-life has risen to the range of 296 4 to 8 minutes. Under elevated c-di-GMP conditions, the half-life of the P 1 -Vc2 sRNA starts at 297 more than twice the length of the wild-type conditions, but then settles into a similar range of 4 298 to 8 minutes (Fig. 5C ). 299 The observed pattern of increasing half-lives is consistent with there being multiple 300 versions of the P 1 -Vc2 sRNA with different rates of decay. Because the P 1 -Vc2 sRNA contains a 301 functional Vc2 aptamer domain, we hypothesize these different versions of transcript to be c- In this report, we describe a novel regulatory mechanism whereby biding of a ligand to a 316 3'-riboswitch regulates the stability of the upstream sRNA. Our findings arose from the 317 observation that the vast majority of Vc2 riboswitch-containing transcripts do not ultimately 318 contain tfoY mRNA. Instead, the upstream tfoY promoters produce two major sRNA species, the 319 most prominent of which, designated as the P 1 -Vc2 sRNA, originates at the P 1-tfoY promoter and 320 features the Vc2 riboswitch at its 3' terminus. Our results are consistent with the results of 321 multiple transcriptomic studies in V. cholerae which have reported numerous sRNAs that map 322 to the VC1721-tfoY intergenic region ( Fig. S1 ) (28-32). 323 Superficially, the observation that increased c-di-GMP leads to production of short 324 transcripts gives an impression that the Vc2 riboswitch serves as a transcriptional terminator. 325 However, our results do not support that conclusion as we did not observe transcription 326 termination mediated by the Vc2 riboswitch in vitro. Furthermore, termination at a site 327 downstream of the riboswitch would not explain how the P 1 -Vc2 sRNA becomes truncated at 328 the immediate 3'-end of the P1 stem that forms the base of the Vc2 aptamer structure. 329 Riboswitches that function by intrinsic termination employ an additional RNA structure, termed 330 the expression platform, which is adjacent to, but separate from, the aptamer domain (33). For 331 the Vc2 riboswitch, no such structure has been identified downstream of the aptamer domain 332 (13, 22). Finally, both primer extension analysis and Northern blotting indicates that 333 transcription initiated at the P 1-tfoY promoter is regularly able to proceed past the riboswitch 334 (10). No evidence, therefore, supports the hypothesis that the Vc2 riboswitch functions by 335 controlling transcription termination. 336 We previously demonstrated that Vc2 bound to c-di-GMP inhibits production of TfoY 337 leading to decreased motility (10). Here, we demonstrate that a second phenotype for Vc2 is 338 the changing abundance of the P 1 -Vc2 and P 2 -Vc2 sRNAs. When intracellular c-di-GMP 339 concentrations are elevated, more P 1 -Vc2 sRNA is present, and mutation of Vc2 to disrupt its 340 structure or ability to bind c-di-GMP leads to less P 1 -Vc2 sRNA. The requirement for formation of the c-di-GMP binding pocket (46). It is no coincidence then that 411 the 3'-end of the P 1 -Vc2 sRNA is located immediately adjacent to the base of the P1 stem and 412 that this was also the site of poly-adenylation for the sRNAs we recovered (Fig. 1) . The doublet 413 sizes of P 1 -Vc2 sRNA transcripts and the pattern of their degradation we observed in our 414 rifampicin stability assay are consistent with distinct populations of 3'-tailed and non-tailed 415 transcripts, which is a hallmark of the 3'-end degradative processes described for many 416 regulatory RNAs in bacteria ( Fig. 5A; (47) ). We hypothesize that closure of the P1 stem of the 417 Vc2 aptamer during a c-di-GMP binding event increases the stability of the P 1 -Vc2 sRNA by 418 making the nucleotides at the 3'-end of the riboswitch transcript inaccessible to 3'-5' 419 exonucleases. 420 Previous work with the Vc2 riboswitch has made note of the exceptionally strong, 421 picomolar affinity of the c-di-GMP aptamer for its ligand as measured in vitro, despite the 422 observation that c-di-GMP concentrations in vivo reside in the nanomolar to low micromolar 423 range (19, 48, 49) . Specifically, ligand binding at the Vc2 aptamer experiences an unusually slow 424 off-rate, so slow, in fact, that each c-di-GMP binding event should effectively be irreversible 425 over the lifetime of the RNA transcript in the cell (19, 48) . For canonical riboswitches that 426 employ transcriptional mechanisms of regulation, the on-rate of ligand binding is the more 427 important feature of aptamer kinetics because a switching decision must be made in the brief 428 window of time that transcription of the expression platform is occurring (50). After initial 429 ligand binding occurs, long-term retention of the ligand by the riboswitch aptamer is 430 unimportant in transcriptional regulation because the RNA polymerase has long passed and a 431 final decision about the "on" or "off" state of downstream gene expression has already been 432 made. Biochemical study of the G20 and C92 sites of the Vc2 aptamer showed that the effect 433 of those mutations was minimal on the c-di-GMP binding on-rate but had a great effect on the 434 off-rate (19, 48) . The slow off-rate of the Vc2 riboswitch is consistent with c-di-GMP-binding 435 serving a continued function throughout the entire lifetime of the P 1 -Vc2 sRNA in the cell by 436 maintaining the Vc2 aptamer in a structure that would make the nucleotides of the aptamer 437 inaccessible to RNAses. 438 An important outstanding question of this research regards the function of the P 1 -Vc2 439 sRNA after expression. This intracellular concentration of P 1 -Vc2 sRNA increases directly with c-440 di-GMP, which suggests it may have a regulatory function at high c-di-GMP. Another interesting 441 question is whether the P 1 -Vc2 sRNA and P 2 -Vc2 sRNA have different targets in the cell or 442 control different phenotypes. One piece of evidence suggesting this might be the case is that 443 the P 2-tfoY promoter is repressed at the level of transcriptional induction by c-di-GMP whereas 444 the P 1-tfoY is not, leading to an increased abundance of the P 1 -Vc2 sRNA at high levels of c-di- 445 GMP and decreased levels of the P 2 -Vc2 sRNA (10). Based on its expression pattern, we predict 446 the P 1 -Vc2 sRNA could regulate traits associated with the biofilm lifestyle of V. cholerae. In all, four RNA probes named probe P 1 , probe P 2 , probe P 1+2 , and probe Vc2 were used, 488 which are complementary to the genomic regions -337 to -272, -272 to -191, -337 to -191, and -489 211 to -94, respectively, relative to the coding sequence of tfoY ( Fig. 2A) . Probes were labeled 490 with Bio-11-UTP during in vitro transcription with the MAXIscript T7 Kit (Ambion) from PCR-491 derived DNA templates containing a consensus T7 promoter fused to the appropriate sequence. Vc2 probe showin in Fig. 2A . It is representative of multiple experiments. The film shown here is 691 overexposed in order to aid the visualization of bands. Values reported in the text were quantified from 692 blots exposed to film over a linear range of detection. DGC=overexpression of QrgB, 
